Novadiscovery takes off with €5 Series A financing

In silico clinical trials pioneer Novadiscovery SA has raised €5m in a series A financing led by Swiss Debiopharm Innovation Fund.

Read more

Alderaan Biotechnology raise €18.5m in Series A financing

Following a €1.5m seed financing in 2017, cancer specialist Alderaan Biotechnology SAS has raised €18.5m in a Series A round led by Advent France Biotechnology and Medicxi.

Read more

Merck and 4SC collaborate in immunooncology

4SC AG and Merck KgaA  have signed a supply agreement to start clinical tests of Merck’s checkpoint blocker avelumab plus 4SC’s HDAC I blocker domatinostat.

Read more

Fighting sepsis mortality

Critical care experts have presented data supporting the thesis that three specific pathways are the cause for about 90% of sepsis mortality.

Read more

Antabio SAS advances cystic fibrosis programme

Antabio SAS has got a US-$4.4m tranche from CARB-X to advance preclinical development of its P. aeruginosa treatment in Cystic Fibrosis patients

Read more

Hydrogel fights wound infection and inflammation

Swedish and Danish researchers have created a hydrogel that kills various types of bacteria and reduces inflammation in mice and pigs with infected wounds.

Read more

Merry Christmas and a Happy New Year

European Biotechnology Magazine will be back with breaking news and backgrounds on 2 January.
Best wishes

Read more